FDA OKs Amitiza for treatment of IBS-C

The U.S. Food and Drug Administration announced approval of Amitiza (lubiprostone) to treat constipation associated with irritable bowel syndrome.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news128790441.html">FDA OKs Amitiza for treatment of IBS-C</a></p> <p>The U.S. Food and Drug Administration announced approval of Amitiza (lubiprostone) to treat constipation associated with irritable bowel syndrome. </p>